ASCLETIS-B (01672) issued a total of 295,600 shares due to the exercise of stock purchase rights.
Gale Pharmaceuticals - B (01672) announced that, due to eligible participants according to the company on June 6, 2019 adopted...
ASCLETIS-B (01672) announced that, as eligible participants exercised their stock options under the company's stock option scheme adopted on June 6, 2019, the company issued a total of 295,600 ordinary shares on September 18, 2025.
Related Articles
Tansun Technology (300872.SZ) plans to grant up to 4.3468 million restricted stocks.
US Stock Market Move | Intel Corporation (INTC.US) surges more than 25% with a $5 billion investment from NVIDIA Corporation.
SILKWAVE INC (00471) completed the issuance of 19,063,900 subscription shares.
Tansun Technology (300872.SZ) plans to grant up to 4.3468 million restricted stocks.
US Stock Market Move | Intel Corporation (INTC.US) surges more than 25% with a $5 billion investment from NVIDIA Corporation.
SILKWAVE INC (00471) completed the issuance of 19,063,900 subscription shares.
RECOMMEND
Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025
Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025
SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025
